L, D., O, A., B, T., A, B., S, P., T, S., . . . R, T. (2026). Effects of Semaglutide on Cardiometabolic Risk in People with Obesity, With and Without Type 2 Diabetes: A Retrospective Observational Study. Journal of clinical medicine, 15(12), . https://doi.org/10.3390/jcm15124421
Chicago Style (17th ed.) CitationL, Deaconu, Albai O, Timar B, Braha A, Popescu S, Sorescu T, Gaita L, Iordan L, and Timar R. "Effects of Semaglutide on Cardiometabolic Risk in People with Obesity, With and Without Type 2 Diabetes: A Retrospective Observational Study." Journal of Clinical Medicine 15, no. 12 (2026). https://doi.org/10.3390/jcm15124421.
MLA (9th ed.) CitationL, Deaconu, et al. "Effects of Semaglutide on Cardiometabolic Risk in People with Obesity, With and Without Type 2 Diabetes: A Retrospective Observational Study." Journal of Clinical Medicine, vol. 15, no. 12, 2026, https://doi.org/10.3390/jcm15124421.